Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
3d
Pharmaceutical Technology on MSNGoogle-backed Isomorphic Labs raises $600m to advance AI drug discoveryThe funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
“This funding will further turbocharge the development of our next-generation AI drug design ... and accelerate drug discovery. The company co-developed AlphaFold 3 with Google DeepMind, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results